MediGene
Medigene AG (FSE: MDG1, ISIN DE000A1X3W00, Prime Standard) is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. Medigene is working on the development of immunotherapies to enhance T cell activity against solid cancers. The first product candidates are in clinical development.
 | |
| Type | Stock company |
|---|---|
| MDG1 | |
| Industry | Biotechnology |
| Founded | 1994 |
| Headquarters | Martinsried, Germany |
Key people | Prof Dolores J Schendel (CEO), Gerd Zettlmeissl (Chairman of the supervisory board) |
| Website | www |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.